Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
•
Hospital Medicine
How often do you check fibrinogen levels and when do you administer FFP for patients with AKI requiring plasma exchange?
Related Questions
What would be your approach to managing severe ANCA-associated vasculitis in a patient who is also septic from a bacterial infection?
What is your treatment approach for pregnant patients with IgA nephropathy who have worsening proteinuria during the first trimester?
Would you recommend genetic testing to determine if there is a potential underlying primary process in a patient with congenital solitary kidney who is presumed to have secondary FSGS?
In which clinical scenarios do you use prolonged intermittent renal replacement therapy (PIRRT)?
Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L?
How do you approach the management of patients with suspected membranous lupus nephritis who are found to have positive PLA2R antibodies?
How long do you wait before arranging AVF placement in patients with AKI who remain dialysis dependent?
Would you consider initiating eculizumab without plasmapheresis as initial therapy for a patient with renal TMA who has a low suspicion of TTP based on a scoring algorithm?
What are your top takeaways from ASN 2024?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
